Increased expression of TRPV1 in DRGs is evident in this model, as well as in a trinitrobenzenesulfonic acid (TNBS) colitis model [47], suggesting that TRPV1 up-regulation may be a mechanism by which the effect of a TRPV1 antagonist becomes manifest [48]. Here, TRPV1 is linked to colitis.